Genetic testing company 23andMe has stirred controversy after it helped develop a new drug using DNA samples collected from its own clients. As Ross Lord reports, it’s raising ethical questions on what those samples are really being used for and whether the company’s customers will be fairly compensated for the drug’s research.
Global National
DNA testing firm 23andMe used client samples for drug development
More Videos
-
U.S. government avoids shutdown hours before deadline
-
Winter weather advisories in place across Canada
-
Germany Christmas market attack: At least 2 dead, dozens injured after man drives car into crowd
-
Who has Trudeau shuffled into his new cabinet?
-
What are Trudeau’s options amid intense pressure to resign?
-
NDP vows to topple Trudeau government in non-confidence vote
You are viewing an Accelerated Mobile Webpage.
View Original Article